BioSpace News Archive

Business

Atara Biotherapeutics to Receive Additional Near-Term Milestone Payment Under Updated Tabelecleucel (Tab-cel®) Commercialization Agreement with Pierre Fabre

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, today announced an update to its existing collaboration agreement with Pierre Fabre for the commercialization of tabelecleucel (tab-cel®) for Epstein-Barr virus (EBV)-positive cancers.

September 28, 2022
·
6 min read
Business

Precision Cancer Consortium Adds New Members in Efforts to Improve Access to Comprehensive Genomic Testing for Patients with Cancer

The Precision Cancer Consortium is pleased to announce the addition of two new members, Lilly and the Janssen Pharmaceutical Companies of Johnson & Johnson.

September 28, 2022
·
1 min read
Bio NC

Asensus Surgical Announces St. Bernhard Hospital in Germany to Initiate Senhance Surgery ProgramSystem to be Utilized by the Oncology-Focused Clinic for General and Visceral Surgery

Asensus Surgical, Inc. today announced the Clinic for General and Visceral Surgery at the St. Bernhard Hospital in Kamp-Lintfort, Germany has entered into an agreement to lease and utilize a Senhance® Surgical System.

September 28, 2022
·
5 min read
Business

Spectrum Chemical Appoints Russell Kneipp as President and CEO, Names Randy Burg Co-Chairman

Spectrum Chemical Mfg. Corp., a leading global provider of fine chemicals, laboratory equipment and supplies, announced the promotion of Russell Kneipp to President and Chief Executive Officer, effective immediately.

September 28, 2022
·
3 min read
Samsung Biologics Earns Gold Rating from EcoVadis for Its Sustainability Efforts

Samsung Biologics was awarded the Gold Sustainability Rating from EcoVadis, a leading global business provider that evaluates the Corporate Social Responsibility performances of companies in areas related to environment, labor and human rights, ethics and sustainable procurement.

September 28, 2022
·
2 min read
BioMidwest

DispatchHealth and Pathnostics Initiate Clinical Study to Compare Guidance UTI® Test to Standard Urine Culture Among Patients Receiving In-Home Care

Pathnostics announced the initiation of an observational study that will enroll a total of 6,800 U.S. patients who are suspected of urinary tract infections, evaluating patient outcomes and management choices based on whether Guidance UTI or Standard Urine Culture was used as the diagnostic test.

September 28, 2022
·
5 min read
Arma Biosciences Announces Efforts Towards a New Biomarker Monitoring System for Virtual Healthcare

Arma Biosciences today announced a joint development effort with Analog Devices, Inc. regarding a new technology platform that is expected to enable remote biomarker monitoring for enhanced virtual healthcare delivery.

September 28, 2022
·
2 min read
Alkermes Announces Launch of 5th Annual Alkermes Pathways Research Awards® Program

Alkermes plc announced that it is now accepting applications for its annual Alkermes Pathways Research Awards® program.

September 28, 2022
·
2 min read
Business

AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2022 Earnings Release

AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2022 Earnings Release.

September 28, 2022
·
2 min read
RetinAI Expands Operations with a U.S. Office In Boston and Achieves 21 CFR Part 11 Compliance to Support Research and Clinical Studies

RetinAI Medical AG (“RetinAI”), is a leader in clinical and imaging data management software and advanced analytics for ophthalmology, is excited to announce the launch of its first U.S.-based office, located in Boston, MA.

September 28, 2022
·
2 min read